| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |